CN108159103B - A kind of Artemisia annua preparation for burn and scald and preparation method thereof - Google Patents
A kind of Artemisia annua preparation for burn and scald and preparation method thereof Download PDFInfo
- Publication number
- CN108159103B CN108159103B CN201810189184.9A CN201810189184A CN108159103B CN 108159103 B CN108159103 B CN 108159103B CN 201810189184 A CN201810189184 A CN 201810189184A CN 108159103 B CN108159103 B CN 108159103B
- Authority
- CN
- China
- Prior art keywords
- preparation
- artemisia annua
- artemisia
- burn
- burns
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 235000001405 Artemisia annua Nutrition 0.000 title claims abstract description 24
- 240000000011 Artemisia annua Species 0.000 title claims abstract description 24
- 206010053615 Thermal burn Diseases 0.000 title claims abstract description 20
- 239000000944 linseed oil Substances 0.000 claims abstract description 17
- 235000021388 linseed oil Nutrition 0.000 claims abstract description 17
- 239000000463 material Substances 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 14
- 239000003921 oil Substances 0.000 claims description 9
- 235000019198 oils Nutrition 0.000 claims description 9
- 235000003826 Artemisia Nutrition 0.000 claims description 8
- 244000030166 artemisia Species 0.000 claims description 8
- 235000009052 artemisia Nutrition 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims description 6
- 235000003097 Artemisia absinthium Nutrition 0.000 claims description 6
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims description 6
- 239000001138 artemisia absinthium Substances 0.000 claims description 6
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 235000007164 Oryza sativa Nutrition 0.000 claims description 4
- 235000009566 rice Nutrition 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 2
- 240000006891 Artemisia vulgaris Species 0.000 claims 2
- 240000007594 Oryza sativa Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 206010063560 Excessive granulation tissue Diseases 0.000 abstract description 3
- 210000001126 granulation tissue Anatomy 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 230000002421 anti-septic effect Effects 0.000 abstract 1
- 230000037390 scarring Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 30
- 229940079593 drug Drugs 0.000 description 14
- 210000003491 skin Anatomy 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 11
- 239000002674 ointment Substances 0.000 description 10
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 8
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 206010039509 Scab Diseases 0.000 description 5
- 206010052428 Wound Diseases 0.000 description 5
- 235000004426 flaxseed Nutrition 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 description 4
- 240000001851 Artemisia dracunculus Species 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 241000208202 Linaceae Species 0.000 description 3
- 235000004431 Linum usitatissimum Nutrition 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 241000209094 Oryza Species 0.000 description 3
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 229960004488 linolenic acid Drugs 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 231100000241 scar Toxicity 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- 206010007558 Cardiac failure chronic Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 206010028851 Necrosis Diseases 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 125000004383 glucosinolate group Chemical group 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 229930013686 lignan Natural products 0.000 description 2
- 150000005692 lignans Chemical class 0.000 description 2
- 235000009408 lignans Nutrition 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- PHZOWSSBXJXFOR-UHFFFAOYSA-N 2-Propenyl glucosinolate Natural products OCC1OC(SC(CC=C)=NOS(O)(=O)=O)C(O)C(O)C1O PHZOWSSBXJXFOR-UHFFFAOYSA-N 0.000 description 1
- 208000012260 Accidental injury Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000208837 Asterales Species 0.000 description 1
- 238000011725 BALB/c mouse Methods 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000003508 Botulism Diseases 0.000 description 1
- 206010051548 Burn infection Diseases 0.000 description 1
- 206010006797 Burns first degree Diseases 0.000 description 1
- 206010006802 Burns second degree Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 208000012239 Developmental disease Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- 206010023215 Joint effusion Diseases 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 208000005228 Pericardial Effusion Diseases 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- PHZOWSSBXJXFOR-MYMDCHNCSA-N Sinigrin Natural products S(=O)(=O)(O/N=C(\S[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)/CC=C)O PHZOWSSBXJXFOR-MYMDCHNCSA-N 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 206010042566 Superinfection Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- QKFAFSGJTMHRRY-OCFLFPRFSA-M potassium;[(e)-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanylbut-3-enylideneamino] sulfate Chemical compound [K+].OC[C@H]1O[C@@H](S\C(CC=C)=N\OS([O-])(=O)=O)[C@H](O)[C@@H](O)[C@@H]1O QKFAFSGJTMHRRY-OCFLFPRFSA-M 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 235000017291 sinigrin Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/55—Linaceae (Flax family), e.g. Linum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于烧烫伤的米蒿制剂及其制备方法,制剂配方包含以下原料:米蒿种子以及辅料,其中所述辅料优选亚麻籽油,本发明对于烧烫伤有明显的止痛消炎、收敛、防腐、促进新生肉芽组织生长以及减少烧烫伤后疤痕增生的功效。The invention discloses an Artemisia annua preparation for burns and scalds and a preparation method thereof. The preparation formula comprises the following raw materials: Artemisia annua seeds and auxiliary materials, wherein the auxiliary materials are preferably linseed oil. , astringent, antiseptic, promoting the growth of new granulation tissue and reducing the effect of scarring after burns.
Description
技术领域technical field
本发明涉及一种用于烧烫伤的米蒿制剂及其制备方法,属于中药技术领域。The invention relates to an Artemisia annua preparation used for burns and scalds and a preparation method thereof, belonging to the technical field of traditional Chinese medicines.
背景技术Background technique
根据现有资料,我国烧伤年发生率约2%,总死亡率约1.35/10万。烧烫伤致伤原因日趋复杂,除了常见的火、沸水等烫伤外,近年来出现了被火锅、摩托车排气管烫伤,多为Ⅱ、Ⅲ度伤,不易痊愈,而且发病率有上升趋势。在0~6岁儿童意外伤害情况调查结果表明:排在第二位的是烧烫伤,烧烫伤比例为13.83%,是儿童致伤致残的主要原因,造成儿童身心发育障碍,还给家庭和社会带来沉重的经济负担【李家伟,景琳,熊颖,潘宇佳,荆媛,赖倩,余伟.农村0~6岁儿童健康管理服务利用现状与儿童健康问题调查分析.中国全科医学,2014,17(30):3590-3593.】。青少年和老年人的烧烫伤一般为生活烧伤,以轻、中度为主。据估计我国约有5%的烧烫伤者需住院治疗,95%轻伤者可在家庭和门诊治疗。住院烧伤病人约有10%发生不同程度的残疾,我国每年因烧烫伤新发生约10万残疾人。According to the available data, the annual incidence of burns in my country is about 2%, and the total mortality rate is about 1.35/100,000. The causes of burns and scalds are becoming more and more complicated. In addition to common burns such as fire and boiling water, burns from hot pot and motorcycle exhaust pipes have occurred in recent years. Most of them are second- and third-degree injuries, which are not easy to heal, and the incidence rate is on the rise. The survey results of accidental injuries among children aged 0-6 show that burns and scalds ranked second, with a proportion of 13.83%, which is the main cause of injury and disability in children, causing physical and mental developmental disorders in children, and returning to the family and the family. The society brings a heavy economic burden [Li Jiawei, Jing Lin, Xiong Ying, Pan Yujia, Jing Yuan, Lai Qian, Yu Wei. Investigation and Analysis of the Utilization Status of Children's Health Management Services and Children's Health Problems in Rural 0-6 Years Old. Chinese General Medicine, 2014, 17(30): 3590-3593.]. The burns of young people and the elderly are generally life burns, mainly mild to moderate. It is estimated that about 5% of burns in my country require hospitalization, and 95% of minor injuries can be treated at home and outpatient clinics. About 10% of hospitalized burn patients suffer from different degrees of disability, and about 100,000 people with disabilities are newly diagnosed with burns and scalds in my country every year.
烧伤创面是烧伤感染、脏器损害等并发症的源头,如何有效地促进创面愈合,一直是烧伤治疗中研究的热点。西医治疗烧烫伤的药物主要是抗生素,长期使用不仅会使细菌产生耐药性并诱发二重感染,还会降低人体的免疫力。中药一直是祖国医学领域的一块瑰宝,中药及其制剂在治疗烧烫伤方面使用广泛、发展迅速、剂型丰富,有着西药无法比拟的优势;烧伤中药在抗感染、促进创面愈合方面也展现了其独特疗效。中药常用于治疗烧伤的中药剂型有:油剂、膏剂、散剂、膜剂、水溶剂、喷雾剂、还有霜剂、成膜剂等【王晓妮,乔彬,周德斌,张建春.中药烧伤膏的研究现状及应用前景.甘肃科技,2016,5(32):124-126.】。中药烧伤膏剂由于其方便、有效的优势一直在中药烧伤药中占有较高的比重。Burn wound is the source of complications such as burn infection and organ damage. How to effectively promote wound healing has always been a hot research topic in burn treatment. The drugs used in western medicine to treat burns and scalds are mainly antibiotics. Long-term use will not only cause bacteria to develop drug resistance and induce superinfection, but also reduce the body's immunity. Traditional Chinese medicine has always been a treasure in the field of medicine in the motherland. Traditional Chinese medicine and its preparations are widely used in the treatment of burns and scald, with rapid development and rich dosage forms, which have incomparable advantages over Western medicine; traditional Chinese medicine for burns also shows its uniqueness in anti-infection and promoting wound healing. curative effect. The traditional Chinese medicine formulations commonly used in the treatment of burns are: oil, ointment, powder, film, water solvent, spray, cream, film-forming agent, etc. [Wang Xiaoni, Qiao Bin, Zhou Debin, Zhang Jianchun. Research on Traditional Chinese Medicine Burn Ointment Status and application prospects. Gansu Science and Technology, 2016, 5(32): 124-126.]. Traditional Chinese medicine burn ointment has always occupied a high proportion in traditional Chinese medicine burn medicine due to its convenient and effective advantages.
经药理和临床试验证明中药油剂、膏剂有很好的疗效,是烧伤外治最常用的制剂之一。外用膏剂中的软膏与膏药在中国应用甚早,在《黄帝内经》(素问)“痈疽篇”中已有“疏砭之,涂以豕膏”的记载。中药烧伤膏主要适用于I度和Ⅱ度烧伤,膏剂富有黏性,外敷患处,既可避免外来刺激和细菌感染,又可消炎止痛,改善局部血液循环,有利于创面组织的修复和再生,适用于各种烧伤创面。Pharmacological and clinical trials have proved that traditional Chinese medicine oil and ointment have good curative effect and are one of the most commonly used preparations for external treatment of burns. The ointment and plaster in the external ointment have been used in China for a long time. In the "Carbuncle Chapter" of the "Huangdi Neijing" (Su Wen), there is a record of "sparse the Bianstone and apply the pig ointment". Traditional Chinese medicine burn ointment is mainly suitable for first-degree and second-degree burns. The ointment is viscous and can be applied externally to the affected area, which can not only avoid external irritation and bacterial infection, but also reduce inflammation and pain, improve local blood circulation, and is conducive to the repair and regeneration of wound tissue. in various burn wounds.
发明内容SUMMARY OF THE INVENTION
本发明所要解决的技术问题是,提供一种对于烧烫伤有明显的止痛消炎、收敛、防腐、促进新生肉芽组织生长以及减少烧烫伤后疤痕增生功效的米蒿制剂。The technical problem to be solved by the present invention is to provide an Artemisia annua preparation with obvious analgesic, anti-inflammatory, astringent, anti-corrosion, promotion of new granulation tissue growth and reduction of scar hyperplasia for burns and scalds.
为解决上述技术问题,本发明采用的技术方案为:In order to solve the above-mentioned technical problems, the technical scheme adopted in the present invention is:
一种用于烧烫伤的米蒿制剂,包含以下原料:米蒿种子以及辅料。A preparation of Artemisia annua for burns and scalds comprises the following raw materials: Artemisia annua seeds and auxiliary materials.
所述辅料优选为亚麻籽油,还可以是其他常用于烧烫伤药的植物油脂或动物油脂等或制成其他剂型所需的辅料,如软膏剂、散剂、膜剂等。The adjuvant is preferably linseed oil, and can also be other vegetable fats or animal fats commonly used in burn and scald medicines, or other adjuvants required for preparation of other dosage forms, such as ointments, powders, films, and the like.
其中,米蒿(Artemisia dalai-lamae)是菊目Asterales、菊科Asteraceae、蒿属Artemisia植物。别名:达赖蒿、驴驴蒿(甘肃、内蒙古),碱蒿(甘肃),“达赖-沙里尔日”(蒙语名)。昧辛、苦,性大寒,具有泻肺定喘,祛痰止咳,行水消肿的功效,能够祛痰定喘、强心利尿、通肠润便。米蒿种子含硫苷(芥子苷,sinigrin)、脂肪油,榨成的油叫米蒿油,对慢性支气管有一定治疗功效;米蒿特有的辛辣味可以刺激身体的代谢机能,含有大量的粗纤维,通便效果明显。《本草纲目》:无毒。《藏药》象才那保:地上部分治炭疽《青藏药鉴》。种子治疫疽药,镇刺痛《中国藏药》。《蒙药》贡图格一布如,哈不毕勒,达瑞雅干:种子用于胆热,肺热,血热,肉毒,水肿,胸满喘咳,胸肋胀痛,肺源性心脏病。其药理作用表明:米蒿种子有强心、利尿、调节血脂、抑制炎性渗出、抗菌、抗癌的作用。临床用于治疗胸腔、腹腔、心包积液;治疗肺部白沫痰和痰多;治疗肺心病慢性心衰,也能治疗其他心脏病之慢性心衰;治疗关节腔积液。Among them, Artemisia dalai-lamae is a plant of the order Asterales, Asteraceae, and Artemisia of the genus Artemisia. Aliases: Artemisia Dalai Lama, Artemisia donkey (Gansu, Inner Mongolia), Artemisia annua (Gansu), "Dalai-Shahrir Day" (Mongolian name). It is pungent, bitter, and cold in nature. It has the effects of purging the lungs and calming asthma, removing phlegm and relieving cough, and removing phlegm and reducing swelling. The seeds of Artemisia annua contain glucosinolates (glucosinolates, sinigrin) and fatty oil. The oil extracted is called Artemisia annua oil, which has a certain therapeutic effect on chronic bronchial tubes. Fiber, laxative effect is obvious. "Compendium of Materia Medica": non-toxic. "Tibetan Medicine" Xiangcai Nabao: the above-ground part of the treatment of anthrax "Qinghai-Tibet Medicine". Seeds cure gangrene, relieve stinging pain "Chinese Tibetan Medicine". "Mongolian Medicine" Gongtuge Yiburu, Habubil, Dariya Gan: Seeds are used for gallbladder heat, lung heat, blood heat, botulism, edema, chest fullness, asthma and cough, chest and ribs pain, pulmonary origin heart disease. Its pharmacological effects show that: Artemisia annua seeds have cardiotonic, diuretic, regulating blood lipid, inhibiting inflammatory exudation, antibacterial and anticancer effects. It is clinically used for the treatment of pleural, abdominal and pericardial effusions; for the treatment of pulmonary foamy phlegm and excessive phlegm; for the treatment of pulmonary heart disease and chronic heart failure, as well as for the treatment of chronic heart failure of other heart diseases; for the treatment of joint effusion.
亚麻籽油是亚麻籽榨取的油类,亚麻籽(flaxseed或linseed)又称胡麻籽,是亚麻科、亚麻属的一年生或多年生草本植物亚麻的种子。亚麻籽油中α-亚麻酸含量为53%,有抗肿瘤,抗血栓,降血脂,营养脑细胞,调节植物神经等作用;亚麻籽油中还含有VE,是一种强有效的自由基清除剂,有延缓衰老和抗氧化的作用;还含有数量可观的高级脂肪醇,甾醇和羟类等。亚麻籽油有以下功效:(1)肌肤娇柔亮泽;(2)改善关节炎;(3)改善器官组织发炎;(4)促进细胞健康;(5)降低胆固醇等多种作用。其中α-亚麻酸和木酚素在烧烫伤中具有消炎、消除瘢痕的作用。因此在本中药制剂组方中亚麻籽油既作为基质使用,同时又具有较好的治疗作用。Flaxseed oil is the oil extracted from flaxseed, flaxseed (flaxseed or linseed), also known as flaxseed, is the seed of flax, an annual or perennial herb of the Flax family and the genus Flax. The content of alpha-linolenic acid in flaxseed oil is 53%, which has the functions of anti-tumor, anti-thrombosis, lowering blood lipids, nourishing brain cells, and regulating autonomic nerves; flaxseed oil also contains VE, which is a strong and effective free radical scavenger. It has anti-aging and antioxidant effects; it also contains a considerable amount of higher fatty alcohols, sterols and hydroxyls. Flaxseed oil has the following effects: (1) Delicate and bright skin; (2) Improve arthritis; (3) Improve organ tissue inflammation; (4) Promote cell health; (5) Reduce cholesterol and other effects. Among them, α-linolenic acid and lignans have anti-inflammatory and scar removal effects in burns. Therefore, the linseed oil is not only used as a matrix, but also has a better therapeutic effect in the traditional Chinese medicine formulation.
以重量份数计,所述米蒿种子用量为10-30份,所述亚麻籽油用量为15-45份。In parts by weight, the amount of the Artemisia annua seeds is 10-30 parts, and the amount of the linseed oil is 15-45 parts.
所述米蒿制剂为油剂。The Artemisia annua preparation is an oil preparation.
一种用于烧烫伤的米蒿制剂的制备方法,包含以下具体步骤:A preparation method of Artemisia annua preparation for burns and scalds, comprising the following concrete steps:
(1)取适量米蒿种子在预热的容器内焙烤,快速翻炒至有爆破声;(1) Take an appropriate amount of wormwood seeds and bake them in a preheated container, and stir-fry quickly until there is a popping sound;
(2)将焙烤好的米蒿种子放凉,研磨成粉末状;(2) let the roasted Artemisia seeds cool, grind into powder;
(3)取适量亚麻籽油,加入研磨好的米蒿粉后,拌合成膏体状即可。(3) Take an appropriate amount of linseed oil, add the ground rice wormwood powder, and mix it into a paste.
步骤(1)中预热温度为100℃,加热时间为3~5秒。In step (1), the preheating temperature is 100° C., and the heating time is 3 to 5 seconds.
本发明所达到的有益效果:本发明中,首次将米蒿种子用于治疗烧烫伤的中药制剂中,将其与亚麻籽油组合使用,既可以将亚麻籽油作为基质使用,同时对于缓解伤后疼痛、防止烫伤部位的感染、促进伤口愈合均有一定帮助,尤其亚麻籽油富含α-亚麻酸、木酚素,起到消炎、消除瘢痕的作用,两者共同作用,可以促进治疗效果。Beneficial effects achieved by the present invention: in the present invention, Artemisia annua seeds are used for the first time in a traditional Chinese medicine preparation for treating burns and scalds, and they are used in combination with linseed oil. Post-pain, preventing infection of the scalded area, and promoting wound healing are all helpful. In particular, flaxseed oil is rich in alpha-linolenic acid and lignans, which can reduce inflammation and eliminate scars. Together, the two can promote the therapeutic effect. .
附图说明Description of drawings
图1是实施例中给人用药后治疗效果图;Fig. 1 is the treatment effect diagram after giving medicine to people in the embodiment;
图2是实施例中给小鼠用药后治疗效果对比图;Fig. 2 is the treatment effect comparison diagram after giving mice medicine in the embodiment;
图3是实施例中给小鼠用药后皮肤病理切片对比图。Figure 3 is a comparison diagram of skin pathological sections after administration to mice in the Example.
具体实施方式Detailed ways
下面结合附图对本发明作进一步描述。以下实施例仅用于更加清楚地说明本发明的技术方案,而不能以此来限制本发明的保护范围。The present invention will be further described below in conjunction with the accompanying drawings. The following examples are only used to illustrate the technical solutions of the present invention more clearly, and cannot be used to limit the protection scope of the present invention.
1、一种用于烧烫伤的米蒿单方油剂1. A kind of rice wormwood single oil preparation for burns and scalds
主要原料为:米蒿种子20g,亚麻籽油30mL。The main raw materials are: Artemisia annua seeds 20g, linseed oil 30mL.
制备方法:(1)取米蒿种子20g,放于预先加热至100℃的瓦片上焙烤3-5秒,同时迅速翻炒至有爆破声;Preparation method: (1) Take 20 g of Artemisia annua seeds, put them on a tile preheated to 100°C and bake for 3-5 seconds, and at the same time stir-fry quickly until there is a popping sound;
(2)将焙烤好的米蒿种子迅速转入白瓷盘中放凉,于研钵中研磨成粉末状;(2) the roasted Artemisia seeds is quickly transferred into the white porcelain plate and allowed to cool, and is ground into powder in a mortar;
(3)取30mL亚麻籽油,加入研磨好的米蒿粉中,拌合成浅棕黄色油状膏体,备用。(3) Take 30 mL of linseed oil, add it to the ground rice wormwood powder, and mix it into a light brown-yellow oily paste for later use.
2、烧烫伤造模实验2. Burn and scald modeling experiment
2.1、实验对象2.1. Experimental subjects
BALB/c小鼠。雌雄各半,平均体重18-22g,清洁级饲养。BALB/c mice. Half male and half female, with an average weight of 18-22g, and kept at clean level.
2.2、实验材料2.2. Experimental materials
LKTC-L,CONTROLLE恒温水浴锅(金坛区西城新瑞仪器厂),手术镊,剪刀,10g砝码(湘仪天平仪器厂),计时器,细绳,脱毛器。LKTC-L, CONTROLLE constant temperature water bath (Jintan District Xicheng Xinrui Instrument Factory), surgical tweezers, scissors, 10g weight (Xiangyi Balance Instrument Factory), timer, string, epilator.
2.3、模型制备2.3. Model preparation
恒温水浴锅加热至100℃并恒温,将拴好细绳的10g砝码,放置于水浴锅中预热约10min,小鼠背部用脱毛器脱毛,乙醚麻醉后,用预热的砝码进行背部热烫5s,同一部位连续热烫两次,在小鼠背部烫出直径1cm的圆形烫伤区,即为Ⅱ级烫伤。The constant temperature water bath was heated to 100°C and kept at a constant temperature. The 10g weight tied with the string was placed in the water bath and preheated for about 10 minutes. The back of the mouse was depilated with an epilator. After ether anesthesia, the back was treated with the preheated weight After scalding for 5 s, the same part was scalded twice in a row, and a circular scalded area with a diameter of 1 cm was scalded on the back of the mouse, which was a grade II scald.
2.4、模型给药2.4. Model drug delivery
将小鼠随机分成2组,即对照组和单方米蒿油剂组,于早中晚分别用棉棒在烫伤部位涂药,每天用药三次。对照组小鼠背部皮肤每天涂抹辅料亚麻籽油,同用药组操作。用药7天后处死小鼠,分别取其损伤皮肤及周围正常皮肤,在4%多聚甲醛中固定2天,石蜡包埋,HE染色,进行组织学的观察。The mice were randomly divided into 2 groups, namely the control group and the single-sided Artemisia annua oil group. The scalded area was smeared with cotton swabs in the morning, noon and evening, three times a day. The back skin of mice in the control group was smeared with linseed oil as an adjunct every day, and the same operation was performed as in the medication group. Mice were sacrificed after 7 days of administration, and the injured skin and surrounding normal skin were removed, fixed in 4% paraformaldehyde for 2 days, embedded in paraffin, and stained with HE for histological observation.
3、治疗效果3. Therapeutic effect
如图1所示,为给人用药后治疗效果,用药2天,皮肤表面红肿、淤血,局部溃烂;用药3天,开始结痂,通过与未结痂部位对比,结痂部位渗出液逐渐减少;用药5天,渗出明显减少,但边沿炎症状态仍然明显;用药7天,结痂已形成完整稳定结构,随后停止用药,用药期间烫伤部位未出现感染等状况;22天后部分结痂层脱落,周围细小伤口开始恢复;51天后,皮肤的表皮真皮趋于恢复状态。As shown in Figure 1, in order to give the therapeutic effect after the administration, the skin surface was red, swollen, bruised, and locally ulcerated for 2 days; after 3 days of administration, scabs began to form. Reduced; after 5 days of medication, the exudation was significantly reduced, but the edge inflammation was still obvious; after 7 days of medication, the scab had formed a complete and stable structure, and then the medication was stopped. After 51 days, the skin's epidermis and dermis tend to recover.
如图2所示,为给小鼠用药后治疗效果对比图,观察发现:对照组小鼠皮肤创伤部分发生烫伤性溃烂,组织严重肿胀,细胞形态模糊变异,4-7天后仍有部分皮肤组织坏死,颜色呈白色与红肿,与周周正常组织形成鲜明的对比;用药组小鼠用药4天后,创面结一层不同程度的红紫色干痂;用药6天后,形成一层较厚的深紫红色干痂;用药7天后,伤口缩小,周围有肉芽组织向内生长,组织上面仍有一层厚厚的结痂。As shown in Figure 2, for the comparison of the therapeutic effect after administration to the mice, it was observed that: the skin wounds of the mice in the control group had scalded ulceration, severe tissue swelling, blurred cell morphology, and some skin tissue after 4-7 days. Necrosis, the color was white and red and swollen, which was in sharp contrast with the normal tissue in the surrounding area. After 4 days of treatment in the mice in the treatment group, a layer of red-purple dry scab was formed on the wound surface; after 6 days of treatment, a thick layer of dark purple was formed. Red dry scab; after 7 days of medication, the wound shrunk, surrounded by granulation tissue ingrowth, and there was still a thick scab on the tissue.
如图3所示,为给小鼠用药后皮肤病理切片对比图,组织形态学镜下观察,与正常小鼠皮肤组织比较,对照组小鼠烫伤皮肤结构发生凝固性坏死,其中表皮及真皮结构损伤严重;部分组织脱落,烫伤深度达到真皮深层,呈深Ⅱ度烫伤特点;用药组小鼠用药7天后,烫伤皮肤组织结构清晰,产生出肥大细胞、巨噬细胞聚集,同时伴有成纤维细胞、胶原物质生成,深层结构逐渐恢复,表皮层次结构日趋完整,皮肤处于恢复状态中。As shown in Figure 3, for the comparison of skin pathological sections after administration to mice, observed under histomorphological microscope, compared with normal mouse skin tissue, the scalded skin structure of mice in the control group had coagulation necrosis, and the epidermis and dermis structure The injury was serious; some tissues fell off, and the scalded depth reached the deep dermis, showing the characteristics of deep second-degree scald; after 7 days of treatment in the mice in the medication group, the structure of the scalded skin was clear, and the accumulation of mast cells and macrophages was accompanied by fibroblasts. , Collagen is generated, the deep structure is gradually restored, the epidermis hierarchy is becoming more and more complete, and the skin is in a state of recovery.
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明技术原理的前提下,还可以做出若干改进和变形,这些改进和变形也应视为本发明的保护范围。The above are only the preferred embodiments of the present invention. It should be pointed out that for those skilled in the art, without departing from the technical principle of the present invention, several improvements and modifications can also be made. These improvements and modifications It should also be regarded as the protection scope of the present invention.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810189184.9A CN108159103B (en) | 2018-03-08 | 2018-03-08 | A kind of Artemisia annua preparation for burn and scald and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810189184.9A CN108159103B (en) | 2018-03-08 | 2018-03-08 | A kind of Artemisia annua preparation for burn and scald and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108159103A CN108159103A (en) | 2018-06-15 |
CN108159103B true CN108159103B (en) | 2020-12-01 |
Family
ID=62511933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810189184.9A Active CN108159103B (en) | 2018-03-08 | 2018-03-08 | A kind of Artemisia annua preparation for burn and scald and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108159103B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112826655B (en) * | 2021-01-05 | 2023-08-11 | 王磊 | Suaeda salsa paste formula and application device thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1701800A (en) * | 2004-05-28 | 2005-11-30 | 高红英 | Externally applied medicine for treating burns and scalds |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101716209A (en) * | 2009-12-02 | 2010-06-02 | 中国科学院西北高原生物研究所 | Artemisia dalai-lamae Krasch. essential oil and preparation method and application thereof |
CN103860691A (en) * | 2012-12-10 | 2014-06-18 | 马本海 | External pure traditional Chinese medicine preparation for treating burns and scalds |
CN104922568A (en) * | 2015-05-28 | 2015-09-23 | 石忠 | Compound oil capable of relieving pain and preparation method thereof |
-
2018
- 2018-03-08 CN CN201810189184.9A patent/CN108159103B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1701800A (en) * | 2004-05-28 | 2005-11-30 | 高红英 | Externally applied medicine for treating burns and scalds |
Also Published As
Publication number | Publication date |
---|---|
CN108159103A (en) | 2018-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2017206758A1 (en) | Topical pharmaceutical composition for treating multiple forms of skin wounds and manufacturing method thereof | |
CN101703598B (en) | Chinese medicinal ointment for treating burn or sore and ulcer and preparation method thereof | |
CN105535334A (en) | Radix arnebiae and milkvetch root granulation-promoting extract and preparation method | |
CN103202903A (en) | Traditional Chinese medicine preparation for treating skin eczema | |
CN103585347B (en) | Chinese medicinal composition for treating burns and scalds and preparation method thereof | |
CN105497960A (en) | Medical dressing with effect of promoting wound healing and manufacturing method | |
CN108159103B (en) | A kind of Artemisia annua preparation for burn and scald and preparation method thereof | |
CN103446240B (en) | Traditional Chinese medicine composition for rapidly healing wounds | |
CN108186901B (en) | A kind of Artemisia annua compound preparation for burn and scald and preparation method thereof | |
CN102688368B (en) | Traditional Chinese medicine for treating trauma hemostasis or telephium | |
CN113197973A (en) | Pharmaceutical composition and preparation method thereof | |
CN105362437A (en) | Prescription of medical ointment for treating decubitus, and preparation method for medical ointment | |
CN108159153B (en) | A kind of Artemisia annua compound preparation for burn and scald and preparation method thereof | |
CN105168625B (en) | A kind of clinical care is used for the treatment of the Chinese medicine liniment of two, three phase decubital ulcers | |
CN108186900B (en) | A kind of Artemisia annua compound preparation for burn and scald and preparation method thereof | |
CN102949456B (en) | Preparation method of Ficus microphylla extract and medicine or wound dressing for promoting wound healing | |
CN111437343B (en) | Inflammation-diminishing and pain-relieving composition, carthamus tinctorius inflammation-diminishing and pain-relieving liquid and preparation method thereof | |
CN109394866B (en) | Paste for removing necrotic tissue and promoting tissue regeneration and preparation method thereof | |
CN103211956B (en) | External poultice for treating burn | |
CN105687630A (en) | Angelica sinensis-elephant skin hide sore and ulcer paste and preparation method thereof | |
CN105497113A (en) | Traditional Chinese medicine composition and application thereof | |
CN112190650A (en) | Traditional Chinese medicine composition and medicament for treating skin wounds | |
CN115607592A (en) | Compound giant knotweed rhizome moist burn cream and preparation method thereof | |
CN117045745A (en) | Traditional Chinese medicine composition for treating anal fissure | |
CN114848778A (en) | Compound hoop ointment for diminishing inflammation, relieving pain and promoting wound healing as well as preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200824 Address after: No. 18877, Jingshi Road, Jinan, Shandong Province Applicant after: Shandong First Medical University (Shandong Academy of Medical Sciences) Address before: 271000 No. 619, the Great Wall Road, Tai'an, Shandong Applicant before: TAISHAN MEDICAL University |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |